مکتبة رقمیه للعلوم الطبيه
Your cart is empty.
  • Cart
  • Lists
    Your lists Log in to create your own lists
  • Log in to your account
  • Your cookies
  • Search history
  • Advanced search
  • Authority search
  • Tag cloud
  • Library

Log in to your account

  1. Home
  2. Details for: A consortium-driven framework to guide the implementation of ICH M7 Option 4 control strategies.
Normal view MARC view ISBD view

A consortium-driven framework to guide the implementation of ICH M7 Option 4 control strategies. [electronic resource]

By:
  • Barber, Chris
Contributor(s):
  • Antonucci, Vincent
  • Baumann, Jens-Christoph
  • Brown, Roland
  • Covey-Crump, Elizabeth
  • Elder, David
  • Elliott, Eric
  • Fennell, Jared W
  • Gallou, Fabrice
  • Ide, Nathan D
  • Jordine, Guido
  • Kallemeyn, Jeffrey M
  • Lauwers, Dirk
  • Looker, Adam R
  • Lovelle, Lucie E
  • McLaughlin, Mark
  • Molzahn, Robert
  • Ott, Martin
  • Schils, Didier
  • Oestrich, Rolf Schulte
  • Stevenson, Neil
  • Talavera, Pere
  • Teasdale, Andrew
  • Urquhart, Michael W
  • Varie, David L
  • Welch, Dennie
Producer: 20180723Description: 22-28 p. digitalISSN:
  • 1096-0295
Subject(s):
  • Computer Simulation
  • Drug Contamination -- prevention & control
  • Humans
  • Mutagenicity Tests -- methods
  • Mutagens -- toxicity
  • Pharmaceutical Preparations -- chemical synthesis
  • Practice Guidelines as Topic
  • Quality Control
  • Quantitative Structure-Activity Relationship
  • Risk Assessment
  • Technology, Pharmaceutical -- standards
Online resources:
  • Available from publisher's website
In: Regulatory toxicology and pharmacology : RTP vol. 90
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Cancel rating. Average rating: 0.0 (0 votes)
  • Holdings ( 0 )
  • Title notes ( 1 )
  • Comments ( 0 )
No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

Log in to your account to post a comment.
Browse results Close
Previous
Back to results
Next
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 41 Piperacillin-tazobactam combination approved by FDA.
  • 42 The Nephrotoxicity of Vancomycin.
    by Filippone, E J
  • 43 Piperacillin/tazobactam-induced immune-mediated thrombocytopenia in the intensive care unit.
    by Boyce, K
  • 44 Evaluating broad-spectrum antimicrobials.
    by Arya, S C
  • 45 Is the Combination of Piperacillin-Tazobactam and Vancomycin Associated with Development of Acute Kidney Injury? A Meta-analysis.
    by Giuliano, Christopher A
  • 46 Severe bleeding caused by piperacillin/tazobactam-induced platelet dysfunction
.
    by Skoric, Bosko
  • 47 National survey of the in vitro spectrum of piperacillin-tazobactam tested against more than 40,000 aerobic clinical isolates from 236 medical centers.
    by Baron, E J
  • 48 Expanded studies of piperacillin/tazobactam formulations: variations among branded product lots and assessment of 46 generic lots.
    by Moet, Gary J
  • 49 Immune hemolysis due to piperacillin/tazobactam.
    by Garcia Gala, J M
  • 50 Severe bone marrow suppression and hepatic dysfunction caused by piperacillin/tazobactam.
    by He, Zhong-Fang
  • 51 Single-Dose Pharmacokinetics of Piperacillin/Tazobactam in Hispaniolan Amazon Parrots ( Amazona ventralis ).
    by Carpenter, James W
  • 52 Vancomycin/Piperacillin-tazobactam Nephrotoxicity in the Critically Ill.
    by Kollef, Marin H
  • 53 Lack of mezlocillin and piperacillin interference in measurement of vancomycin in the Abbott TDx.
    by Merritt, J
  • 54 Should We Revisit the Nephrotoxic Potential of Piperacillin-Tazobactam as Well?
    by Manian, Farrin A
  • 55 Prolonged Infusions: The Significance of How.
    by Colton, Benjamin
  • 56 By ZEUS! Can We Use Intravenous Fosfomycin for Complicated Urinary Tract Infections?
    by Harris, Patrick N A
  • 57 [Piperacillin: a choice position].
    by Acar, J F
  • 58 Reply to Manian.
    by Pogue, Jason M
  • 59 Galactomannan detection from piperacillin-tazobactam brands available in the Brazilian market.
    by Xavier, Melissa Orzechowski
  • 60 The effect of methylprednisolone on treatment in rats with induced sepsis.
    by Cetinkaya, Riza Aytaç
Close

A consortium-driven framework to guide the implementation of ICH M7 Option 4 control strategies.

APA

Barber C., Antonucci V., Baumann J., Brown R., Covey-Crump E., Elder D., Elliott E., Fennell J. W., Gallou F., Ide N. D., Jordine G., Kallemeyn J. M., Lauwers D., Looker A. R., Lovelle L. E., McLaughlin M., Molzahn R., Ott M., Schils D., Oestrich R. S., Stevenson N., Talavera P., Teasdale A., Urquhart M. W., Varie D. L. & Welch D. (20180723). A consortium-driven framework to guide the implementation of ICH M7 Option 4 control strategies. : Regulatory toxicology and pharmacology : RTP.

Chicago

Barber Chris, Antonucci Vincent, Baumann Jens-Christoph, Brown Roland, Covey-Crump Elizabeth, Elder David, Elliott Eric, Fennell Jared W, Gallou Fabrice, Ide Nathan D, Jordine Guido, Kallemeyn Jeffrey M, Lauwers Dirk, Looker Adam R, Lovelle Lucie E, McLaughlin Mark, Molzahn Robert, Ott Martin, Schils Didier, Oestrich Rolf Schulte, Stevenson Neil, Talavera Pere, Teasdale Andrew, Urquhart Michael W, Varie David L and Welch Dennie. 20180723. A consortium-driven framework to guide the implementation of ICH M7 Option 4 control strategies. : Regulatory toxicology and pharmacology : RTP.

Harvard

Barber C., Antonucci V., Baumann J., Brown R., Covey-Crump E., Elder D., Elliott E., Fennell J. W., Gallou F., Ide N. D., Jordine G., Kallemeyn J. M., Lauwers D., Looker A. R., Lovelle L. E., McLaughlin M., Molzahn R., Ott M., Schils D., Oestrich R. S., Stevenson N., Talavera P., Teasdale A., Urquhart M. W., Varie D. L. and Welch D. (20180723). A consortium-driven framework to guide the implementation of ICH M7 Option 4 control strategies. : Regulatory toxicology and pharmacology : RTP.

MLA

Barber Chris, Antonucci Vincent, Baumann Jens-Christoph, Brown Roland, Covey-Crump Elizabeth, Elder David, Elliott Eric, Fennell Jared W, Gallou Fabrice, Ide Nathan D, Jordine Guido, Kallemeyn Jeffrey M, Lauwers Dirk, Looker Adam R, Lovelle Lucie E, McLaughlin Mark, Molzahn Robert, Ott Martin, Schils Didier, Oestrich Rolf Schulte, Stevenson Neil, Talavera Pere, Teasdale Andrew, Urquhart Michael W, Varie David L and Welch Dennie. A consortium-driven framework to guide the implementation of ICH M7 Option 4 control strategies. : Regulatory toxicology and pharmacology : RTP. 20180723.

  • Print
  • Cite
  • Add to your cart (remove)
  • Save record
    BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
  • More searches
    Search for this title in:
    Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Visit web site